ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 98 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $324,000 | -15.4% | 80,700 | +150.2% | 0.00% | – |
| Q2 2021 | $383,000 | +181.6% | 32,257 | +197.9% | 0.00% | – |
| Q1 2021 | $136,000 | -95.7% | 10,827 | -96.5% | 0.00% | -100.0% |
| Q4 2020 | $3,167,000 | +11.2% | 309,238 | -22.4% | 0.00% | 0.0% |
| Q3 2020 | $2,847,000 | +21800.0% | 398,249 | +15659.8% | 0.00% | – |
| Q2 2020 | $13,000 | -23.5% | 2,527 | -12.5% | 0.00% | – |
| Q4 2019 | $17,000 | +70.0% | 2,887 | +46.0% | 0.00% | – |
| Q3 2019 | $10,000 | -16.7% | 1,978 | -7.4% | 0.00% | – |
| Q2 2019 | $12,000 | – | 2,137 | +106750.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 2 | -99.3% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 300 | +154.2% | 0.00% | – |
| Q3 2018 | $2,000 | +100.0% | 118 | +4.4% | 0.00% | – |
| Q2 2018 | $1,000 | – | 113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |